Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Hair Loss Biopharma Firm Veradermics Raises $256 Million in IPO

Veradermics Inc., a biopharmaceutical firm focused on hair restoration, raised $256.3 million in an upsized US initial public offering priced above the top of its marketed range.
A woman pulling hair from a hairbrush
The late clinical-stage biopharmaceutical firm is developing its lead therapy to treat mild-to-moderate pattern hair loss, according to its filing. (Shutterstock)

Veradermics Inc., a biopharmaceutical firm focused on hair restoration, raised $256.3 million in an upsized US initial public offering priced above the top of its marketed range.

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.

In This Article

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.

In a Pricing Pinch, Mass Beauty Brands Get Creative

Lower-priced beauty brands are feeling the pinch as fixed costs rise and customers reign in their spending. To grow, brands will need to rebuild creative muscle to improve product development and maximise marketing.


view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.

In a Pricing Pinch, Mass Beauty Brands Get Creative

Lower-priced beauty brands are feeling the pinch as fixed costs rise and customers reign in their spending. To grow, brands will need to rebuild creative muscle to improve product development and maximise marketing.


VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON